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Abstract
Protein misfolding underlies the pathology of a large number of human disorders, many of which are age-
related. An exception to this is preeclampsia, a leading cause of pregnancy-associated morbidity and mortality
in which misfolded proteins accumulate in body fluids and the placenta. We demonstrate that pregnancy zone
protein (PZP), which is dramatically elevated in maternal plasma during pregnancy, efficiently inhibits in vitro
the aggregation of misfolded proteins, including the amyloid beta peptide (Aβ) that is implicated in
preeclampsia as well as with Alzheimer's disease. The mechanism by which this inhibition occurs involves the
formation of stable complexes between PZP and monomeric Aβ or small soluble Aβ oligomers formed early
in the aggregation pathway. The chaperone activity of PZP is more efficient than that of the closely related
protein alpha-2-macroglobulin (α2M), although the chaperone activity of α2M is enhanced by inducing its
dissociation into PZP-like dimers. By immunohistochemistry analysis, PZP is found primarily in extravillous
trophoblasts in the placenta. In severe preeclampsia, PZP-positive extravillous trophoblasts are adjacent to
extracellular plaques containing Aβ, but PZP is not abundant within extracellular plaques. Our data support
the conclusion that the up-regulation of PZP during pregnancy represents a major maternal adaptation that
helps to maintain extracellular proteostasis during gestation in humans. We propose that overwhelming or
disrupting the chaperone function of PZP could underlie the accumulation of misfolded proteins in vivo.
Attempts to characterize extracellular proteostasis in pregnancy will potentially have broad-reaching
significance for understanding disease-related protein misfolding.
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Protein misfolding underlies the pathology of a large number of
human disorders, many of which are age-related. An exception to
this is preeclampsia, a leading cause of pregnancy-associated
morbidity and mortality in which misfolded proteins accumulate
in body fluids and the placenta. We demonstrate that pregnancy
zone protein (PZP), which is dramatically elevated in maternal
plasma during pregnancy, efficiently inhibits in vitro the aggrega-
tion of misfolded proteins, including the amyloid beta peptide (Aβ)
that is implicated in preeclampsia as well as with Alzheimer’s dis-
ease. The mechanism by which this inhibition occurs involves the
formation of stable complexes between PZP and monomeric Aβ or
small soluble Aβ oligomers formed early in the aggregation path-
way. The chaperone activity of PZP is more efficient than that of
the closely related protein alpha-2-macroglobulin (α2M), although
the chaperone activity of α2M is enhanced by inducing its dissoci-
ation into PZP-like dimers. By immunohistochemistry analysis, PZP
is found primarily in extravillous trophoblasts in the placenta. In
severe preeclampsia, PZP-positive extravillous trophoblasts are ad-
jacent to extracellular plaques containing Aβ, but PZP is not abun-
dant within extracellular plaques. Our data support the conclusion
that the up-regulation of PZP during pregnancy represents a major
maternal adaptation that helps to maintain extracellular proteostasis
during gestation in humans. We propose that overwhelming or dis-
rupting the chaperone function of PZP could underlie the accumulation
of misfolded proteins in vivo. Attempts to characterize extracellular
proteostasis in pregnancy will potentially have broad-reaching signif-
icance for understanding disease-related protein misfolding.
protein misfolding | molecular chaperones | proteostasis | pregnancy |
preeclampsia
Normal healthy pregnancy is a state in which physiologicalstresses that are capable of inducing protein misfolding are
considerably heightened. In part, these stresses are the conse-
quence of a systemic inflammatory response involving the gen-
eration of reactive oxygen species (1), which contribute to a
measurable increase in the oxidation of maternal plasma pro-
teins (2). The placenta, which is the interface between the
mother and the developing fetus, is another major contributor to
the generation of reactive oxygen species, due to its high level of
metabolic activity (reviewed in ref. 3). Additionally, body tem-
perature is slightly, but chronically, elevated during pregnancy
(4), and a tremendous increase in blood volume promotes shear
stress (5, 6). As pregnancy advances, the fetoplacental unit pro-
duces many new secreted proteins that all need to be trafficked and
ultimately cleared by maternal organs under these physically un-
favorable conditions. Remarkably, virtually nothing is known re-
garding the way that the maternal body adapts to handle the unique
protein homeostasis (proteostasis) challenges of pregnancy.
Significance
Pregnancy is a unique physiological state involving biological
stresses that promote protein damage (misfolding) within the
maternal body. Currently, little is known regarding how the
maternal body copes with elevated protein misfolding in
pregnancy. This is important, because the accumulation of
misfolded proteins underlies many human disorders, including
preeclampsia, a serious complication of pregnancy. In this
study, we show that pregnancy zone protein (PZP) efficiently
inhibits the aggregation of misfolded proteins, including the
amyloid beta peptide, which forms plaques in preeclampsia
and in Alzheimer’s disease. We propose that up-regulation of
PZP is a major maternal adaptation that helps to maintain
protein homeostasis during pregnancy. Moreover, pregnancy-
independent up-regulation of PZP indicates that its chaperone
function could be broadly important in humans.
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Aberrant accumulation of misfolded proteins in extracellular
fluids underlies the pathology of a large number of age-related
disorders, including Alzheimer’s disease, macular degeneration,
arthritis, and atherosclerosis (7). Aside from these age-related
disorders, misfolded proteins have been shown to accumulate in
the urine, serum, and the placenta of women with preeclampsia
(8–12), a leading cause of pregnancy-related morbidity and
mortality. The broad spectrum of disorders known to involve
protein misfolding highlights the fact that proteins are vulnerable
to misfolding as a consequence of genetic and environmental
changes (13), including pressures that occur as a normal part of
pregnancy in mammals. A collapse in the proteostasis network is
recognized as a key event associated with aging and ultimately
death (14). Intuitively, to cope with pregnancy-associated phys-
iological stresses, the functions of the pregnancy-associated
proteostasis network will be critically important.
A small number of normally secreted proteins including clusterin,
haptoglobin, and alpha-2-macroglobulin (α2M) have been shown to
stabilize and inhibit the aggregation of misfolded proteins (reviewed
in ref. 15). Collectively, these proteins are known as extracellular
chaperones. Levels of known extracellular chaperones do not in-
crease significantly in maternal blood during normal healthy preg-
nancy (16–19). Therefore, it is conceivable that one or more
pregnancy-associated proteins, which are up-regulated during gesta-
tion, play a major role in stabilizing misfolded proteins. Of the nu-
merous changes that occur in the maternal plasma proteome during
pregnancy, one of the most dramatic is the increase in pregnancy
zone protein (PZP) levels. The concentration of PZP in human
blood plasma is normally <0.03 mg/mL, but by 30 wk of gestation
PZP levels can reach up to 1.5 to 3 mg/mL in some individuals (20).
It is currently unclear why the body makes this tremendous in-
vestment in the up-regulation of PZP in pregnancy when levels of
α2M, a closely related α-macroglobulin (αM) family member, are
constitutively high in human blood plasma [∼1.5 to 2 mg/mL (21)].
In humans, α2M (a tetramer) and PZP (a dimer) share 71%
sequence homology (22), and are historically best known as
protease inhibitors. However, compared with α2M, PZP is rela-
tively inefficient at performing this activity, and PZP–protease
interactions have only been described for a restricted number of
protease substrates in vitro (23–27). In more recent years, the
multifunctional nature of α2M has become apparent (reviewed in
ref. 28). For example, reaction of α2M with hypochlorite, an
oxidant that is produced during inflammation, induces the dis-
sociation of the native α2M tetramer into dimers (29, 30). The
hypochlorite-induced dissociation of α2M into dimers results in a
loss of the protease-trapping activity of α2M (30) but a potent
activation of its chaperone activity (29). Compared with the
native α2M tetramer, α2M dimers preferentially bind not only to
misfolded proteins but also to a variety of other ligands, in-
cluding signaling molecules (29, 31, 32). Given that PZP is
normally a dimer in biological fluids, we hypothesized that PZP
could be an efficient chaperone that stabilizes misfolded proteins
in a manner similar to dimeric α2M. In the present study, we
examined the effect of purified PZP on the fibrillar aggregation
of the Aβ peptide associated with Alzheimer’s disease, which has
also been implicated in pathological changes occurring in the
placenta in preeclampsia (8). To increase the physiological rel-
evance of our studies, we investigated the aggregation propensity
of proteins in pregnancy plasma in situ and determined the lo-
calization of PZP in placental tissue from women with pre-
eclampsia and of control women matched by gestational age.
Results
Pregnant Women with Low PZP Levels Do Not Compensate by Up-
Regulating α2M. PZP was purified from pooled human pregnancy
plasma as described previously (33). When analyzed by native
Western blotting, purified PZP migrated to the same position as
PZP in heparin-treated human pregnancy plasma (Fig. 1A). This
was important to assess, because purified PZP has a tendency to
aggregate during extended storage, a process that has functional
consequences (34). The polyclonal anti-PZP antibody used in
these experiments did not react with highly purified α2M, veri-
fying its specificity for PZP (Fig. 1A). By native gel analysis, the
migration of purified PZP was faster than that of native and
transformed α2M (α2M*; a compact tetrameric form generated
by reaction of the α2M thioester bond) but comparable to that of
hypochlorite-liberated α2M dimers (Fig. 1B). The latter migrated
in a more diffuse manner compared with PZP, consistent with a
heterogeneous population of species differing slightly in physical
properties that are present in the hypochlorite-modified α2M
preparation (29). The results of native Western blot analyses
indicated that there was marked variation in plasma levels of
PZP between individuals matched for gestational age (36 wk),
while plasma levels of α2M were comparatively similar in all of
the samples examined (Fig. 1C). Densitometric analysis of α2M
and PZP (collectively referred to as αMs) in pregnancy plasma
indicated that there is only a weak correlation between PZP and
α2M levels (R2 = 0.2236) (Fig. 1D). The latter result supports the
conclusion that individuals with low PZP in pregnancy do not
compensate by up-regulating α2M.
PZP Inhibits Aβ1–42 Amyloid Formation More Efficiently than Native
α2M. The ability of purified PZP to inhibit the fibrillar aggrega-
tion of the 42-residue isoform of the Aβ peptide (Aβ1–42) was
assessed using the well-established thioflavin T (ThT) assay.
Under the conditions used, Aβ1–42 aggregated over a period of
∼10 h following a short lag phase of ∼1 h (Fig. 2A). Coincubation
of Aβ1–42 with PZP both extended the lag phase and reduced the
rate of fibril formation in a dose-dependent manner (Fig. 2A).
Compared with the native α2M tetramer, PZP more efficiently
inhibited the ThT fluorescence associated with the formation of
amyloid fibrils of Aβ1–42, except at the lowest ratio of αM to Aβ1–42
tested (i.e., 1 molecule of α2M or PZP to 80 molecules of Aβ1–42)
(Fig. 2A). In the latter case, both native α2M and PZP reduced
the initial rate of fibril formation but did not significantly reduce
the overall ThT fluorescence at the conclusion of the assay.
Consistent with our previous report (29), α2M dimers (generated
by pretreatment with hypochlorite and purified by size-exclusion
Fig. 1. Western blot and native PAGE analyses of PZP in human pregnancy
plasma and following purification. (A) Image of a Western blot showing the
migration of PZP pre- and postpurification from pregnancy plasma, after
separation using a 3 to 8% Tris-acetate native gel. The position of PZP is
indicated with an arrow. A corresponding amount of purified α2M was not
detected (final lane). (B) Image of a 3 to 8% Tris-acetate native gel showing
the migration of purified PZP, α2M, transformed α2M (an electrophoretically
fast tetramer), and hypochlorite-modified α2M (α2M ox). The positions of αM
tetramers and dimers are indicated. (C) Images of Western blots showing the
relative PZP levels in eight individual pregnant women at 36 wk gestation.
Pregnancy plasma (1 μL) was separated using a 3 to 8% Tris-acetate native
gel, and proteins were transferred to a nitrocellulose membrane. The blot
was initially probed using an anti-PZP antibody, and then the same blot was
reprobed using an anti-α2M antibody. Images show the major bands de-
tected, and are cropped and realigned to assist comparison of the respective
levels of PZP and α2M present. (D) Densitometry analysis of Western blots
showing the relative levels of PZP and α2M in 14 individual women at 36 wk
of pregnancy. R2 is calculated using Pearson’s correlation coefficient.
6102 | www.pnas.org/cgi/doi/10.1073/pnas.1817298116 Cater et al.
chromatography) inhibited Aβ1–42–associated ThT fluorescence
far more efficiently than the native α2M tetramer in all experi-
ments (Fig. 2A). Comparatively, the effect of PZP was less than
that of the hypochlorite-modified α2M dimer preparation, except
at the highest ratio of αM to Aβ1–42 tested (i.e., 1 molecule of
PZP or α2M dimer to 20 molecules of Aβ1–42), when the two
dimeric proteins had similar effects. The results of a bisANS
(4,4-dianilino-1,1-binaphthyl-5,5-disulfonic acid) assay suggest
that surface-exposed hydrophobicity underpins the chaperone
activity of αMs (Fig. 2B). Consistent with the results of prior
studies (35, 36), our data show that native PZP is relatively more
hydrophobic than native α2M. In the case of the hypochlorite-
modified α2M dimer, the dramatically elevated surface hydro-
phobicity is the combined effect of the dissociation of the nor-
mally buried hydrophobic interface of noncovalently associated
α2M dimers and of hypochlorite-induced perturbations to the
secondary structure of α2M (29). Considering that tetrameric
α2M (720 kDa) and PZP (360 kDa) are both composed of mo-
nomeric αM subunits (180 kDa), comparison of native α2M and
PZP at equivalent molar ratios (as in Fig. 2A) is biased in terms
of total αM subunit number (and mass) in favor of α2M. There-
fore, we reevaluated the ability of native α2M and PZP to inhibit
Aβ1–42–associated ThT fluorescence under conditions where the
total numbers of αM subunits were equivalent (Fig. 2C). The
latter experiment demonstrates that on a subunit basis, the ability
of native PZP to inhibit Aβ1–42–associated ThT fluorescence is
substantially greater than that of native α2M in vitro.
Qualitative analysis by transmission electron microscopy
(TEM) indicated that aggregation of Aβ1–42 alone resulted in
assemblies with morphologies consistent with amyloid fibrils
(Fig. 3A). The relative abundance of fibrillar material observed
correlated closely with the results of the ThT assays whereby
Fig. 2. Effects of the α2M tetramer, α2M dimer, and PZP on the aggregation
of Aβ1–42 as assessed by ThT assay. (A) Aβ1–42 (5 μM) was incubated with
25 μM ThT in PBS at 32 °C with constant shaking. Aβ1–42 was also coincubated
with either native α2M, PZP, or SEC-purified α2M dimer at molar ratios of (i)
1:80, (ii) 1:40, or (iii) 1:20 (αM to Aβ1–42) under the same conditions. The
results shown are the average ThT fluorescence (excitation, 440 nm; emis-
sion, 480 nm; n = 4 ± SEM) in arbitrary fluorescence units (AFUs), and are
representative of three independent experiments. The symbol * denotes
significantly reduced ThT fluorescence compared with Aβ1–42 alone and
corresponding samples coincubated with native α2M as assessed at the end
of the assay [Tukey honest significant difference (HSD), P < 0.05], and **
denotes significantly reduced ThT fluorescence compared with Aβ1–42 alone
as assessed at the end of the assay (Tukey HSD, P < 0.05). (B) Corresponding
bisANS analysis of αM preparations as described in A. The data are the mean
bisANS fluorescence (excitation, 360 ± 10 nm; emission, 490 ± 10 nm) of
triplicate samples ±SEM and are corrected for background fluorescence. *
denotes significantly higher bisANS fluorescence of PZP compared with na-
tive α2M (Tukey HSD, P < 0.01), and ** denotes significantly higher bisANS
fluorescence of dimeric α2M compared with native α2M and PZP (Tukey HSD,
P < 0.01). (C) The effects of native α2M and PZP on amyloid formation were
examined using an αM subunit-to-Aβ1–42 ratio of 1:20; under these condi-
tions the masses of α2M and PZP used in the assay are equivalent. The results
shown are the average ThT fluorescence (AFUs) of triplicate samples and are
representative of three independent experiments. Error bars are the SEM.
The symbol * denotes significantly reduced ThT fluorescence compared with
Aβ1–42 alone and corresponding samples coincubated with native α2M as
assessed at the end of the assay (Tukey HSD, P < 0.05).
Fig. 3. TEM images of Aβ1–42 after coincubation with α2M tetramer, α2M dimer,
or PZP, and correspondingmeasurements of soluble Aβ1–42. (A) Aβ1–42 (5 μM)was
incubated ± native α2M, PZP, or SEC-purified α2M dimer at a molar ratio of 1:20
(αM to Aβ1–42) at 32 °C with constant shaking for ∼15 h. Samples of the protein
solutions were snap-frozen in liquid nitrogen before analysis by TEM. (Scale bars,
100 nm.) (B) After incubation as described in A, insoluble Aβ1–42 was removed by
centrifugation (21,000 × g) and soluble Aβ1–42 was quantified by densitometry
following Western blot analysis (n = 3 ± SEM). The density of soluble Aβ1–42 in
samples containing dimeric αMs (gray) is presented relative to soluble Aβ1–42 in
samples containing native tetrameric α2M (black). N.D., not detected; N.S., not
significantly different (Tukey honest significant difference; P > 0.05).








coincubation with the native α2M tetramer appeared less effi-
cient at inhibiting fibril formation compared with PZP and the
hypochlorite-modified α2M dimer, respectively (Fig. 3A). In
samples containing Aβ1–42 and PZP, small nonfibrillar aggre-
gates that were relatively uniform in size and morphology were
present. Interestingly, quantification of the concentration of
soluble Aβ1–42 at the conclusion of the assay indicated that under
the conditions used, coincubation with PZP or hypochlorite-
modified α2M dimers retained a similar amount of Aβ1–42 in
the soluble fraction (Fig. 3B). Corresponding samples containing
Aβ1–42 coincubated with native α2M, however, contained less
than 10% of the levels of soluble Aβ1–42 present after coincu-
bation with dimeric αMs (Fig. 3B). Following incubation of Aβ1–42
in the absence of any of the proteins at 37 °C, soluble Aβ1–42 could
not be detected.
PZP Forms Stable Complexes with Aβ1–42. We have previously
reported that monomeric Aβ1–42 and/or small soluble species
formed early in the aggregation pathway bind to hypochlorite-
modified α2M but do not bind to the native α2M tetramer in vitro
(29). Consistent with this report, when Hilyte-labeled Aβ1–42 was
coincubated with native α2M and then subjected to native gel
electrophoresis, negligible comigration of labeled Aβ1–42 with the
α2M tetramer was detected (Fig. 4A). In contrast, when Hilyte-
labeled Aβ1–42 was coincubated with either hypochlorite-
modified α2M or PZP, significant levels of labeled Aβ1–42
comigrating with these proteins during native gel electrophoresis
were detected in both cases (Fig. 4A). The formation of stable
PZP–Aβ1–42 complexes was confirmed using a streptavidin–
biotin pull-down assay, and demonstrated that PZP (180 kDa)
coeluted with biotinylated Aβ1–42 at much greater levels than was
the case for the nonspecific binding of PZP to the streptavidin
beads alone (Fig. 4B). Although monomeric Aβ1–42 could not be
detected comigrating with the native α2M tetramer (Fig. 4A),
when analyzed by native Western blotting, comigration of Aβ1–42
and the native α2M tetramer was detected if the peptide was
preincubated to induce its aggregation (SI Appendix, Fig. S1).
PZP Inhibits Heat-Induced Protein Aggregation.Considering that the
accumulation of misfolded proteins in preeclampsia is not lim-
ited to the Aβ peptide (8–12), we examined the effect of PZP on
the heat-induced aggregation of citrate synthase (CS), a model
protein used to form amorphous protein aggregates. Heating of
CS at 43 °C induced its aggregation over a period of ∼5 h as
measured by the absorbance of the solution at 595 nm (i.e.,
turbidity), and coincubation of CS with PZP reduced the level of
CS aggregation in a dose-dependent manner (Fig. 5A). At a
1:2.5 molar ratio (PZP to CS), the inhibitory effect of PZP on the
aggregation of CS was significantly greater than the comparable
effect of native α2M at the conclusion of the assay (Fig. 5A). For
clarity, kinetic curves (Fig. 5 A, i) and statistical analysis of end-
point absorbance values (Fig. 5 A, ii) are presented separately.
To examine the possibility that monomeric αMs also stabilize
misfolded proteins in vitro, the chaperone activities of native
α2M, PZP, and monomeric Escherichia coli α2M (ECAM) were
directly compared using heat-denatured creatine phosphokinase
(CPK; another commonly used model protein that forms
amorphous aggregates). The results of these assays indicate that,
like tetrameric α2M, monomeric ECAM is relatively ineffective
in suppressing heat-induced CPK aggregation compared with
PZP (Fig. 5B). We have previously shown that hypochlorite-
modified α2M dimers more efficiently inhibit amorphous pro-
tein aggregation compared with the native α2M tetramer (29);
the available evidence therefore supports the conclusion that
dimeric quaternary structure is important for the chaperone
activity of the αMs. To verify that purified ECAM did not ab-
errantly form higher-order assemblies such as dimers or tetra-
mers, a native gel showing the migration of purified ECAM
compared with reduced monomeric α2M is provided in SI Ap-
pendix, Fig. S2.
Using conditions that are known to induce plasma protein
precipitation (37, 38), the aggregation propensities of plasma
proteins from preeclamptic women or women experiencing un-
complicated pregnancy (control) were examined in situ. The two
types of pooled plasma samples examined were similar in terms
of their total protein levels and maternal ages, but the pooled
preeclampsia plasma sample contained ∼50% less PZP than the
control, and the mean gestational ages of the two cohorts dif-
fered by several weeks (Table 1). The data show that after 500 h
of incubation, the turbidity of the PZP-deficient pooled plasma
sample from preeclamptic women had increased significantly,
but no significant change was detected in the pooled sample
from matched controls (Fig. 5C). Combined together, these re-
sults support the conclusion that similar to other extracellular
chaperones (15), PZP stabilizes a range of misfolded protein cli-
ents, including aggregation-prone peptides and denatured proteins.
Endogenous Proteases Do Not Induce the Formation of Tetrameric
PZP in Blood Plasma in Situ. As previously mentioned, demon-
stration of the protease-trapping action of PZP has currently
been limited to studies involving purified protein in vitro (23–
27). In the present study, to evaluate the protease-trapping ac-
tion of purified PZP versus PZP in plasma, the effects of in-
cubation with chymotrypsin were determined. When purified
Fig. 4. αM–Aβ1–42 complexes detected by native PAGE and biotin–streptavidin
pull-down assay. (A, i ) Fluorescence image of a native gel showing the
migration of Hilyte Fluor 488-labeled Aβ1–42 after incubation alone or with
αMs at a 1:10 molar ratio of αM:Aβ1–42. α2M ox and α2M ox2 denote α2M
pretreated with 25 and 100 μM NaOCl, respectively, followed by dialysis to
remove unreacted NaOCl. All samples were incubated for 30 min at ambient
room temperature. (A, ii) Following fluorescence imaging, the gel was
stained with Instant Blue and reimaged to determine the position of all
proteins. (B) Image of a Western blot detecting PZP recovered by biotin–
streptavidin pull-down assay after incubation in the presence (+) or absence
(−) of biotinylated Aβ1–42 for 30 min at room temperature. Samples were
incubated at a molar ratio of PZP:Aβ1–42 1:10 and were subjected to de-
naturing gel electrophoresis under reducing conditions before Western blot
analysis. Under these conditions, the PZP dimer migrates as a 180-kDa
monomer. The positions of molecular-mass markers (Mr) are shown in kDa.
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PZP was coincubated with chymotrypsin (molecular mass
25 kDa), a small amount of PZP was found to form a high-
molecular-mass species (Fig. 6A). This result supports a pro-
posed model for protease trapping in which two PZP molecules
form a tetrameric complex around the covalently bound protease
(23). Interestingly, when human pregnancy plasma was incubated
at 37 °C for 45 min and assessed by native Western blot analysis,
there was negligible evidence that a similar high-molecular-mass
PZP species is formed under these conditions in situ (Fig. 6 B, i).
Moreover, supplementation of the plasma with 1 μM chymo-
trypsin had no observable effect on the migration of PZP. In the
same plasma samples, native α2M was converted to an electro-
phoretically fast form (similar to α2M*; Fig. 1B), and the effect
was greater when the plasma was supplemented with chymo-
trypsin (Fig. 6 B, ii). The latter behavior is consistent with pro-
tease trapping by α2M, which causes the α2M tetramer to become
compact (24). In contrast to the anti-α2M antibody that was
found to bind strongly to protease-bound electrophoretically fast
α2M (Fig. 6 B, ii), the anti-PZP polyclonal antibody used in this
study bound preferentially to the native PZP dimer (SI Appendix,
Fig. S3). Given that the putative PZP–protease complexes were
not detected in situ following the addition of high levels of
chymotrypsin (Fig. 6B), densitometry was used to confirm that
the levels of native PZP in plasma were not detectably reduced
following the addition of chymotrypsin (Fig. 6C).
PZP Is Predominantly Absent from Extracellular Aβ Deposits in
Preeclampsia. We have previously reported the presence of am-
yloid precursor protein proteoforms in amyloid-like plaques in
placentas from women with severe preeclampsia comorbid with
fetal growth restriction (8). To identify if there is potential for
PZP to act as a local chaperone in the placenta, we performed
immunohistochemical analysis of well-characterized cases of
preterm birth with and without preeclampsia and/or fetal growth
restriction; relevant clinical information pertaining to these
samples is provided in SI Appendix, Table S1. Extravillous tro-
phoblasts (EVTs) in the basal plate, placental septa, and cell
islands stained strongly for PZP in all clinical scenarios, but
several patterns emerged relative to histological changes in pla-
centa that are commonly associated with preeclampsia (Fig. 7 A–C).
In the maternal floor of the placenta of idiopathic preterm
birth, PZP-positive EVTs were seen scattered (Fig. 7A); in pre-
eclampsia, however, they appeared to migrate around avascular
villi (Fig. 7 B and C), thus contributing to the characteristic “lacy
appearance” of confluent placental islands (Fig. 7D) classically
described in preeclamptic placentas populated by increased
numbers of proliferating migratory EVTs (39, 40). Staining of
serial sections supported the notion that these cells also harbor
Aβ (Fig. 7E) as well as cytokeratin-7 (Fig. 7F), thus confirming
their trophoblast phenotype.
To determine whether or not PZP colocalizes with Aβ in in-
soluble plaques in vivo, we performed double-immunofluorescence
studies with a particular focus on confluent placental islands
(Fig. 7 H–J). EVTs that were stained intensely red for PZP were
seen surrounding acellular areas in the vicinity of extracellular
green fluorescent Aβ deposits (orange arrows, Fig. 7H) and
isolated EVTs, which appeared morphologically necrotic (white
arrows). The vicinity between extracellular Aβ and dying EVTs
was better appreciated using confocal imaging (Fig. 7I). Upon
z-stack reconstruction, zones of merged yellow fluorescence
suggested that a small amount of PZP was codeposited with Aβ
in plaques (Fig. 7J, blue arrows), although it is clear that de-
posited Aβ is not predominantly bound to PZP. Further analysis
of the intracellular location of PZP and Aβ is presented in SI
Appendix, Fig. S4.
Discussion
Consistent with the functions of PZP having systemic importance
throughout pregnancy, PZP levels are dramatically elevated in
blood plasma from an early stage during gestation (20). The
latter is a relevant observation, as the accumulation of misfolded
proteins is not isolated to the placenta in preeclampsia but has
been measured in serum and urine (8, 9, 12). The results of this
study demonstrate that PZP stabilizes Aβ and other misfolded
client proteins more efficiently than the constitutively abundant
α2M tetramer, which has received substantial attention for its
role as an extracellular chaperone (reviewed in ref. 15). Given
the extent to which PZP is up-regulated in mid to late pregnancy,
it is conceivable that PZP is a major regulator of extracellular
proteostasis during gestation. However, it is probable that PZP
does not act alone to stabilize misfolded proteins in maternal
fluids [e.g., modest chaperone-like activity has been reported for
the pregnancy-associated SERPINB2 (41)]. Thus, the results
Fig. 5. Effect of αMs on the heat-induced aggregation of CS. (A) CS at 1 μM
was incubated at 43 °C ± PZP or α2M. The molar ratios of αM:CS used are
shown. Turbidity was monitored using absorbance at 595 nm. The data
shown in i are the mean of triplicate samples and are representative of two
independent experiments. For clarity, the mean absorbance at 595 nm
(A595 nm) at the end point of the assay including error bars is provided in ii
(n = 3 ± SEM). The symbol * denotes significantly reduced turbidity com-
pared with the control sample containing CS alone (black bar) [Tukey honest
significant difference (HSD), P < 0.05], and ** denotes significantly reduced
turbidity compared with the sample containing CS alone and the sample
containing a corresponding amount of α2M (shaded area) (Tukey HSD, P <
0.05). (B) Turbidity assay showing CPK (5 μM) incubated at 55 °C in PBS ±
ECAM, PZP, or α2M. The molar ratio of αM:CPK was 1:5. Turbidity was
monitored using absorbance at 595 nm. The data shown are individual
measurements and are representative of two independent experiments. (C)
Pooled plasma from individuals exhibiting normal uncomplicated pregnancy
(control) or preeclampsia (Table 1) was incubated at 38 °C for 500 h and
routinely agitated. The turbidity was assessed using A595 nm. A bar chart
displaying the mean A595 nm is shown (n = 4 ± SEM) and is representative of
two independent experiments. The symbol † denotes significantly increased
A595 nm at 500 h compared with 0 h (Student’s t test, P < 0.05).
Table 1. Characteristics of plasma samples that were pooled
from individuals exhibiting preeclampsia or uncomplicated
pregnancy (control)
Characteristic Preeclampsia Control
Total protein, mg/mL 59 ± 1 60 ± 1
PZP*, mg/mL 0.22 ± 0.004 0.46 ± 0.011
Maternal age, y 33 ± 6.0 34 ± 3.9
Gestational age*, wk 33 ± 2.7 28 ± 1.5
Individual samples pooled, n 9 6
*Significant difference between the two cohorts (Student’s t test, P < 0.05).








generated from the current study provide an important first step
toward understanding how the maternal body adapts to handle
the unique challenges to extracellular proteostasis during pregnancy.
A Model for the Related Chaperone Mechanisms of PZP and α2M.Our
data show that native PZP (a dimer) exposes greater hydrophobic
surface area to solution than native tetrameric α2M, and binds to
Aβ monomers and/or small Aβ oligomers that do not form stable
complexes with native α2M. Therefore, the results of this study
support a model in which binding sites for Aβ (and other misfolded
proteins) are present on constitutively exposed hydrophobic sur-
faces of the native PZP dimer that, in the closely related native α2M
tetramer, are located at the normally buried hydrophobic interface
between pairs of disulfide-linked α2M dimers (42, 43). Consistent
with this model, we have previously shown that hypochlorite-
induced dissociation of the native α2M tetramer enhances its
binding to Aβ (29). Although the precise binding sites for Aβ on
PZP are not yet known, a previously reported binding site for Aβ on
α2M (centered at amino acids 1314 to 1365, but sterically shielded
in the native α2M tetramer 44) shares 85.7% sequence identity with
the corresponding region of PZP (SI Appendix, Fig. S5).
The available data suggest that native α2M can be rapidly in-
duced to become PZP-like via hypochlorite-induced dissociation
(29), which potentially acts as an important first line of defense
that transiently increases αM-mediated chaperone activity during
severe inflammation. Considering that elevated myeloperoxidase
levels have been reported in preeclampsia (45), it is plausible
that hypochlorite-modified α2M is transiently generated during
an advanced stage of the syndrome that corresponds to severe
inflammatory processes. Further studies to identify the precise
conformations of hypochlorite-modified α2M that are generated
during inflammation and to define their relative abundance are
needed to appreciate fully the importance of this process in vivo.
Given the highly multifunctional nature of α2M, the current
study paves the way for evaluating whether or not other activities
that are enhanced by dissociation of the native α2M tetramer,
such as binding to cytokines (32), are also important roles
for PZP.
The Chaperone Activity of PZP Potentially Influences Pregnancy-
Associated and Pregnancy-Independent Protein Misfolding. Interest
in the role of α2M in Alzheimer’s disease spans several decades,
with a number of early genetic studies reporting an association
between mutations in α2M and the risk of disease (46–49). This
association has not, however, been confirmed by more recent
genome-wide association studies (reviewed in ref. 50), which
suggests that additional factors such as posttranslational modifi-
cation could be important. Interestingly, elevated levels in serum
of α2M or PZP are reportedly associated with presymptomatic
Alzheimer’s disease in men and women, respectively (51, 52).
Furthermore, both α2M and PZP are found to be colocalized with
Aβ in the brain in Alzheimer’s disease (53, 54). It is not yet known
if the elevated levels of PZP measured in women with pre-
symptomatic Alzheimer’s disease are the consequence of a general
innate immune system response, since PZP levels are reported to
be elevated in several other inflammatory states including rheu-
matoid arthritis (55), Behçet’s syndrome (56), psoriasis (57, 58),
Chagas disease (59), and viral infection (60, 61). Nevertheless, the
available data strongly suggest that both α2M and PZP are likely to
participate in Aβ homeostasis in vivo. It remains to be determined
whether or not their roles are overlapping or discrete.
Previous studies have reported that low levels of maternal
plasma PZP are associated with spontaneous preterm birth (62)
and an increased risk of preeclampsia (63–65). On the other
hand, opposing and inconclusive data have also been reported
regarding a negative correlation between maternal plasma PZP
levels and preeclampsia (66, 67). As such, there is a need to
reevaluate this association with greater consideration of both the
clinical spectrum of preeclampsia (68) and the accurate quanti-
fication of PZP independent of the closely related α2M, which
even modern proteomic methods have struggled to distinguish
from each other (67). Although detailed analysis of the chaper-
one activity of PZP in pregnancy plasma in situ is outside of the
scope of the current study, our results provide an indication that
PZP deficiency could contribute to the accumulation of mis-
folded proteins in preeclampsia. Consistent with this idea, high
levels of plasma PZP are associated with pregnancy-associated
remission of rheumatoid arthritis (69), a condition exacerbated
by the accumulation of damaged proteins in the synovial fluid of
inflamed joints (70, 71). However, our inability to assay a large
number of samples from individual women with preeclampsia
and matched controls is a limitation of this study. Additionally,
preeclampsia is a complex multifactorial syndrome, and pre-
viously reported immunomodulatory activities (17, 72–74) or
currently undescribed functions of PZP that mirror the multi-
functional nature of α2M could also be important (reviewed in
ref. 75).
It has previously been reported that microglia that are im-
munoreactive for PZP colocalize with Aβ deposits in the brain in
Alzheimer’s disease (53). The pathobiological relevance of PZP
expression at sites of Aβ deposition, however, remains unclear.
Fig. 6. αM–protease complex formation in vitro and in situ. (A) Image of a
native gel showing the migration of purified native PZP and PZP–protease
complexes. Putative PZP–protease complexes were generated by pre-
incubation with chymotrypsin (chym) at a 2:1 molar ratio of PZP to chym for
30 min at 37 °C. (B) Native Western blot analysis showing putative αM–
protease complexes in human pregnancy plasma. Heparinized human
pregnancy plasma was incubated at 37 °C for 45 min in the presence or
absence of 1 μM chym. An additional sample was held at 4 °C on ice for the
same period (control). Blots probed for (i) PZP or (ii) α2M are from the same
experiment. The expected positions of the PZP–chym and α2M–chym com-
plexes are indicated. (C) The band corresponding to the native PZP dimer
was quantified using densitometry in pregnancy plasma treated as described
in B. The graph shows the mean PZP level relative to the control (n = 5 in-
dependent experiments ± SD).
6106 | www.pnas.org/cgi/doi/10.1073/pnas.1817298116 Cater et al.
Given that our data demonstrate that PZP is found in extra-
villous trophoblasts in cell islands adjacent to placental Aβ pla-
ques, there is a need to establish the relative contributions of
fetal and maternal plasma PZP to normal placental function,
including Aβ homeostasis. The observation that PZP is largely
excluded from Aβ plaques in the placenta supports our hypoth-
esis that PZP normally forms soluble complexes with Aβ that are
subsequently taken up by cells and cleared. Codeposition of PZP
with Aβ in the placenta in preeclampisa could indicate that the
chaperone activity of PZP or receptors responsible for its
clearance is overwhelmed or dysfunctional in the syndrome. The
intriguing cytoplasmic and nuclear localization of PZP observed
in the placenta suggests that this protein might also have cur-
rently undescribed intracellular roles (SI Appendix, Fig. S4).
Using STRING analysis (76), nuclear importins 7 and 8 are
predicted to bind to PZP with medium confidence, although
further studies are needed to examine this possibility.
PZP Is Not a Major in Situ Inhibitor of Proteases in Pregnancy Plasma.
The emergence of the α2M tetramer from a dimeric precursor
appears to have been driven by evolutionary pressures (77).
However, it is clear that in many mammals, including humans,
dimeric PZP has relevance in pregnancy- and in non–pregnancy-
associated inflammatory states. Although α2M and PZP share
extensive sequence identity, such identity does not occur in the
protease bait region (21), which explains why the broad-spectrum
protease inhibitory activity of α2M is not shared by PZP. Con-
sistent with the results of several other in vitro studies, the results
generated here using human pregnancy plasma in situ support
the conclusion that α2M is much more proficient at trapping
abundant endogenous plasma proteases compared with PZP
(23–25). Given that protease trapping is currently the only bi-
ologically relevant mechanism known to expose the LRP1
binding site on PZP (35), it is plausible that this reaction occurs
in vivo. If it does occur, however, the identities of the major
protease substrates are currently unclear. Proteases from the
fibrinolytic and coagulation cascade have been proposed as po-
tential targets of PZP (27), but conflicting results have also been
presented (78). When the protease specificity of the PZP bait
region is analyzed using the bioinformatics tool PROSPER, cleavage
sites are predicted for both metalloproteases matrixmetallopeptidase-
2 and -9 and for serine proteases elastase-2 and cathepsin G (79).
Limited in vitro data also suggest that metalloproteases and in-
tracellular proteases, including elastase, might be endogenous
substrates for PZP (24, 26). On the other hand, given that all of
these proposed protease substrates are more efficiently trapped by
the α2M tetramer than by the PZP dimer (24, 26), it is difficult to
imagine that the up-regulation of PZP in pregnancy is exclusively
linked to its protease-trapping function.
Pregnancy-Associated Maternal Adaptations Contribute to Proteostasis.
Research into the extracellular quality control of protein folding
has primarily been driven by the knowledge that misfolded
proteins accumulate in a large number of age-related disorders
such as Alzheimer’s disease, arthritis, atherosclerosis, and mac-
ular degeneration. The pregnancy-associated syndrome pre-
eclampsia clearly stands apart from these conditions. On the
other hand, mature age and pregnancy can both be viewed as life
Fig. 7. Immunolocalization of PZP in the human preterm placenta. (A–C) Representative micrographs of the maternal floor of the placenta at the interface
between the basal plate (bp) and villous tissue (vt) in (A) iPTB, idiopathic preterm birth (gestational age-matched control); (B) sPE, severe preeclampsia; and
(C) sPE+FGR, fetal growth restriction. (D–F) Serial sections of placenta from a woman with early-onset sPE+FGR showing a confluent placental cell island (cpci)
at the interface between villous tissue and the chorionic plate (cp). The sections have been immunostained for (D) PZP, (E) Aβ, and (F) cytokeratin-7 (CK7). (G)
Negative control slide exposed to nonimmune rabbit IgG. Vector Red was used as peroxidase substrate and hematoxylin as counterstain. The Insets show at
higher magnification regions populated by extravillous trophoblasts which are arranged in an orderly manner in iPTB but border many avascular ghost villi in
preeclampsia (black arrows). (Scale bars, 100 μm.) (H–J) Confocal microscopy of placenta from two women with sPE+FGR double-immunostained for PZP (red
fluorescence) and Aβ (green fluorescence). DAPI was used as nuclear counterstain. (H) A confluent placental cell island populated by PZP-positive extravillous
trophoblasts and plaque-like deposits of extracellular Aβ (orange arrows); dead or dying cells in the vicinity of Aβ deposits (white arrows); trophoblasts
staining positive for PZP surround many avascular ghost villi (white asterisks). Higher magnification of the area in H framed in continuous line (I) with ad-
ditional magnification and z-stack 3D reconstruction of the area framed in H (J). The irregular cellular shape and loss of nuclear DAPI staining suggest cell
death. The blue arrows point to intensely yellow fluorescence generated by proximity of PZP and Aβ epitopes. (Scale bars, 50 μm.)








stages that involve chronically elevated physiological stresses that
contribute to protein misfolding (2, 14). In addition to the ac-
cumulation of misfolded protein aggregates, there are numerous
similarities between preeclampsia and many age-related protein-
misfolding disorders, including strong inflammatory pathology
and vascular dysfunction (80, 81). Furthermore, it has been
shown that premature placental aging underlies early-onset
preeclampsia (82), and it has been proposed that the placenta
is a tractable model for aging human tissue (83). Interestingly,
recent data suggest that, after preeclampsia, women have a
fourfold increased risk of death from Alzheimer’s disease than
the general female population (84). While potentially explained
by increased cardiovascular and cerebrovascular disease rates in
this group, common pathophysiologies related to protein mis-
folding might also play a role. Therefore, it is tempting to
speculate that a greater understanding of the maternal adapta-
tions for controlling protein misfolding in pregnancy could help
us to understand better the phenomenon of age-related protein
misfolding and hence to contribute to the development of novel
therapeutic strategies.
Materials and Methods
All chemicals and buffer salts were obtained from Sigma-Aldrich, unless
otherwise stated.
PZP and α2M Purification from Human Plasma. Heparinized human pregnancy
plasma was obtained from donors as approved by either the Cambridgeshire
2 Research Ethics Committee (reference no. 07/H0308/163) or the joint Uni-
versity of Wollongong (UOW) and Illawarra Shoalhaven Local Health District
(ISLHD) Health and Medical Human Research Ethics Committee (application
nos. 2013/377 and 2016/1016) and stored at ≤−20 °C until use. All partici-
pants provided written informed consent. Donated blood samples were
deidentified before use in this study as specified in the relevant approved
ethics applications. This included donations from women with no known
pregnancy complication (control) and women diagnosed with preeclampsia.
PZP was subsequently purified from control pregnancy plasma as described
in ref. 33.
Native α2M was purified from normal (i.e., nonpregnant) blood plasma
without amendment as described in ref. 85. This collection was approved by
the joint UOW and ISLHD Health and Medical Human Research Ethics
Committee (application no. HE02/080). Transformed α2M was generated by
incubating 1.4 μM native α2M with 400 mM NH4Cl in PBS (pH 7.4) overnight at
room temperature, followed by extensive dialysis against PBS. Hypochlorite-
modified α2M was generated by incubating 0.55 μM α2M with 120 μM NaOCl
in PBS overnight at ambient room temperature, followed by extensive dialysis
against PBS to remove unreacted NaOCl. Hypochlorite-modified α2M dimers
were purified from residual α2M tetramer via Superose 6 10/300 GL size-
exclusion chromatography (SEC).
Electrophoresis and Western Blot Analyses. Proteins were subjected to native
gel electrophoresis using NuPAGE Novex 3 to 8% Tris-acetate gels and Novex
Tris-glycine native buffers (Life Technologies). Denaturing gel electrophoresis
was performed using NuPAGE Novex 4 to 12% Bis-Tris gels and NuPAGE Mes
SDS running buffer. Where specified, samples were reduced by treatment
with β-mercaptoethanol. Gels were stained using Instant Blue stain (Sigma-
Aldrich). In experiments involving Hilyte-labeled Aβ1–42, the migration of the
fluorescently labeled peptide was determined using a Typhoon Trio imager
(GE Healthcare).
For Western blot analysis, proteins were subjected to electrophoresis as
described above and transferred to nitrocellulose or polyvinylidene difluoride
(PVDF) membrane. After blocking overnight at 4 °C in skim milk solution [5%
(wt/vol) skim milk powder in PBS], the membranes were incubated with the
relevant antibodies/streptavidin conjugates diluted in skim milk solution (1 h
at 37 °C). Blots were imaged with an Amersham 600 imager (GE Healthcare)
using enhanced chemiluminescence. PZP was detected using an affinity-
purified polyclonal antibody (GeneTex), α2M was detected using monoclo-
nal antibody 2N1/10 (Bio-Rad) or a polyclonal antibody (Dako), and Aβ1–42
was detected using monoclonal antibody W02 supernatant.
Thioflavin T Assays. Aβ1–42 (5 μM; AnaSpec) was incubated at 32 °C with
shaking in PBS containing ThT (25 μM) in the presence or absence of native
α2M, PZP, or hypochlorite-modified α2M dimer (pretreated using NaOCl and
purified from residual tetramers by SEC as described above). The ThT fluores-
cence of the samples was continuously monitored using a FLUOstar OPTIMA
plate reader (BMG Labtech) with excitation and emission wavelengths of
440 and 480 nm (slit widths of 10 nm), respectively. At the conclusion of the
assay, following brief centrifugation to pellet insoluble material (5 min at
21,000 × g), the relative amount of soluble Aβ1–42 in each sample was
measured by subjecting 20 μL of the supernatant to native Western blot
analysis and performing densitometry using ImageJ software (NIH). The
density of soluble Aβ1–42 in samples containing dimeric αMs is presented
relative to soluble Aβ1–42 in samples containing native tetrameric α2M.
4,4-Dianilino-1,1-Binaphthyl-5,5-Disulfonic Acid Assay. For bisANS analyses,
170 nM native α2M tetramer, native PZP dimer, or hypochlorite-modified
α2M dimer was incubated with 10 μM bisANS in PBS for 5 min at ambient
room temperature before the fluorescence was measured on a FLUOstar
OPTIMA plate reader with excitation and emission wavelengths of 360 and
490 nm (slit widths of ±10 nm), respectively. All reported values are cor-
rected for the background fluorescence of bisANS in PBS.
Transmission Electron Microscopy. Aβ1–42 was incubated in the presence or
absence of native α2M, PZP, or oxidized α2M dimer as described for ThT
assays. The samples were then applied to 400-mesh carbon film copper grids
(Agar Scientific) and imaged on an FEI Tecnai G2 transmission electron mi-
croscope (CAIC; University of Cambridge). Images were analyzed using the
SIS Megaview II Image Capture System (Olympus).
Biotin–Streptavidin Pull-Down Assays. Binding of PZP to commercially pre-
pared biotinylated Aβ1–42 (bAβ1–42; Cambridge Bioscience) was performed
following their coincubation at a 1:10 molar ratio of PZP to bAβ1–42 in PBS
for 10 min at ambient room temperature. Biotin–streptavidin pull-down
assays were performed using Dynabeads My One Streptavidin C1 accord-
ing to the manufacturer’s instructions (Life Technologies).
Turbidity Assays. CS (1 μM in PBS; Sigma-Aldrich) was incubated in the
presence or absence of native PZP or native α2M at 43 °C in a FLUOstar
OPTIMA plate reader while the absorbance at 595 nm was continuously
monitored. For clarity, kinetic curves and analysis of end-point absorbance
values are presented in separate charts. In other experiments, CPK (5 μM in
PBS; Sigma-Aldrich) was incubated in the presence or absence of ECAM, PZP,
or α2M at 55 °C while the absorbance at 595 nm was continuously monitored
as described above. Recombinant ECAM was purified as described in ref. 86.
The plasmid used for purifying ECAM was a gift from Andréa Dessen,
Structural Biology Institute (IBS), Grenoble, France.
Using methods similar to previous studies, we assessed the aggregation of
protein in human plasma in situ (37, 38). Briefly, heparinized blood plasma
samples from individuals exhibiting uncomplicated pregnancy (n = 6) or
preeclampsia (n = 9) were pooled. Total protein was estimated using the
bicinchoninic acid assay, and the plasma was supplemented with 0.01%
NaN3 to prevent microbial growth during the assay. PZP quantification was
performed using an R&D Systems ELISA kit according to the manufacturer’s
instructions (In Vitro Technologies). Four 70-μL aliquots of pooled plasma
from each cohort were dispensed into a Griener 384-well plate and in-
cubated at 38 °C for 500 h with periodic agitation in a FLUOstar OPTIMA
plate reader (BMG Labtech). The absorbance at 595 nm was measured as an
indicator of plasma turbidity.
Protease-Trapping Assays. The protease-trapping activity of purified PZP was
examined after incubation with chymotrypsin at a 2:1 molar ratio of PZP to
chymotrypsin for 30 min at 37 °C by subjecting the proteins to separation
using native gel electrophoresis. Under these conditions, protease trapping
is detected by the formation of a high-molecular-mass complex consisting of
two molecules of PZP and one molecule of protease (23). To examine the
ability of PZP to trap proteases in heparinized human pregnancy plasma in
situ, plasma was incubated at 37 °C for 45 min in the presence or absence of
1 μM chymotrypsin. An additional sample (not supplemented with chymo-
trypsin) was held on ice to limit the activity of endogenous plasma protease.
Following separation using 3 to 8% Tris-acetate gels, proteins were trans-
ferred to PVDF membranes and probed for PZP or α2M (as described in
Electrophoresis and Western Blot Analyses).
Placental Immunohistochemistry and Immunofluorescence. We analyzed pla-
cental tissues of women with medically indicated delivery in the context of
early-onset severe preeclampsia [n = 11; gestational age (GA) at delivery
(mean ± SD): 30 ± 3 wk]. Tissues from a group of women with spontaneous
6108 | www.pnas.org/cgi/doi/10.1073/pnas.1817298116 Cater et al.
idiopathic preterm birth at a similar gestational age (n = 8; GA: 30 ± 2, P =
0.453) served as the best possible control. All women delivered at Yale-New
Haven Hospital and provided signed informed consent under protocols ap-
proved by the Human Investigation Committee of Yale University. Donated
tissues were deidentified before use in this study as specified in the relevant
approved ethics application. Within minutes of the time of delivery of the
placenta, a full-thickness biopsy was retrieved from the central portion of
the placenta and fixed in formalin and embedded in paraffin. Five-
micrometer serial sections were deparaffinized in xylene and rehydrated
with graded ethanol to potassium PBS solution (pH 7.2). Following antigen
retrieval with citrate buffer, sections were pretreated with 1% hydrogen
peroxide for 15 min followed by incubation for 1 h at room temperature
with 5% donkey serum (Jackson ImmunoResearch Laboratories). Sections
were then incubated overnight at 4 °C with primary antibodies followed by
incubation for 1 h at room temperature with biotinylated donkey anti-
rabbit or anti-mouse IgG (1:600; Jackson ImmunoResearch Laboratories) as
appropriate. Signal amplification and detection were performed with avi-
din–biotin (VECTASTAIN Elite ABC; Vector Laboratories) using Vector
NovaRed as peroxidase substrate. Sections exposed to nonimmune IgG
served as negative control. The following primary antibodies were used:
polyclonal anti-PZP (1:100; GeneTex), monoclonal anti-Aβ antibodies (clone
W0-2; Millipore), monoclonal anti–cytokeratin-7 (1:100; Invitrogen), and
monoclonal anti–HLA-G (1:100; clone 4H80; Abcam).
To colocalize PZP with Aβ, we performed double immunofluorescence on
select tissues. After deparaffinization and antigen retrieval with citrate
buffer, the slides were blocked with 100 mM glycine followed by 10% goat
serum for 1 h at room temperature. Slides were further incubated overnight
at 4 °C with the mixture of primary antibodies anti-PZP (1:100) and anti-
Abeta (clone W02; 1:250). Following washing, slides were exposed for 1 h at
room temperature to a secondary antibody mixture containing 2 μg/mL goat
anti-mouse IgG conjugated to Alexa Fluor 488 and 2 μg/mL goat anti-rabbit
IgG conjugated to Alexa Fluor 594 plus 1 μg/mL DAPI. Slides were mounted
with ProLong Gold Antifade medium and images were captured using a
Zeiss LSM 700 confocal laser-scanning microscope.
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